Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

Even if the market didn’t reward Progressive in 2025, the fundamentals remained intact. PGR is still one of the best-in-class ...

Capital Southwest offers mid-single digit returns with a 96.6% floating-rate portfolio, strong credit, and moderate NII ...

Founder Reports looks at how leadership approaches designed for in-office environments can be improved to meet the needs of ...

Preliminary Preclinical Data Demonstrates In Vivo Proof-of-Concept for Novel Diabetes Gene Therapy in Type 2 Diabetic Non-Human Primates GPX-002 Rejuvenated Exhausted ...

Backblaze’s latest price target update sits in a tight US$9 to US$11 range, and that narrow band highlights how closely growth hopes and execution risk are being weighed right now. Bulls see sector ...

Calumet, Inc. (NASDAQ: CLMT) (the "Company," "Calumet," "we," "our" or "us") announced today preliminary selected financial ...

You've probably experienced it. That moment when you open a food delivery app, your stomach rumbling, craving your favorite ...

Discover how to navigate the complexities of forex trading in South Africa with our comprehensive roadmap, designed to help ...

Learn how to create burndown charts to track project progress, improve team performance, and download free templates to get ...

According to recent data from the Centers for Disease Control and Prevention (CDC), Texas now falls into the “very high” ...